Shandong Weigao Group increases treasury holdings with new share repurchase

Shandong Weigao Group Medical Polymer Company Limited (HKEX:1066) repurchased 109,200 H shares through the Exchange on November 11, 2025. The shares were acquired at prices ranging from HK$5.32 to HK$5.34 each, for an aggregate cost of HK$582,344.

This transaction added 109,200 shares to the company's treasury holdings, bringing the total number of treasury shares to 23,910,000. As a result, the company's total issued shares (excluding treasury shares) decreased by 109,200, from 4,498,531,524 to 4,498,422,324.

The company holds a repurchase mandate, authorized on May 27, 2025, for up to 451,560,392 shares. Following this latest repurchase, the total number of shares repurchased under the current mandate stands at 17,261,600. A moratorium period for issuing new shares or transferring treasury shares is in effect until December 10, 2025.